Healthcare provider profile · identity verified

Aldo Prosperi, MD

Family Practice · LATROBE, PA · NPI 1811975527

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	532	113
Levothyroxine Sodium	Levothyroxine Sodium	524	95
Lisinopril	Lisinopril	429	104
Losartan Potassium	Losartan Potassium	396	102
Atorvastatin Calcium	Atorvastatin Calcium	362	93
Rosuvastatin Calcium	Rosuvastatin Calcium	337	80
Metformin Hcl	Metformin Hcl	298	72
Omeprazole	Omeprazole	276	54
Tamsulosin Hcl	Tamsulosin Hcl	269	61
Furosemide	Furosemide	251	72
Metoprolol Tartrate	Metoprolol Tartrate	244	60
Pantoprazole Sodium	Pantoprazole Sodium	241	62
Sertraline Hcl	Sertraline Hcl	228	50
Gabapentin	Gabapentin	216	39
Hydrochlorothiazide	Hydrochlorothiazide	205	44
Simvastatin	Simvastatin	184	48
Prednisone	Prednisone	171	99
Lorazepam	Lorazepam	148	41
Xarelto	Rivaroxaban	128	19
Tramadol Hcl	Tramadol Hcl	127	37
Escitalopram Oxalate	Escitalopram Oxalate	120	23
Potassium Chloride	Potassium Chloride	115	29
Trazodone Hcl	Trazodone Hcl	110	18
Azithromycin	Azithromycin	98	65
Repaglinide	Repaglinide	93	15
Albuterol Sulfate Hfa	Albuterol Sulfate	92	31
Montelukast Sodium	Montelukast Sodium	91	21
Metoprolol Succinate	Metoprolol Succinate	85	22
Pravastatin Sodium	Pravastatin Sodium	85	21
Amoxicillin	Amoxicillin	84	69
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	17
Clopidogrel	Clopidogrel Bisulfate	82	21
Eliquis	Apixaban	82	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	34
Duloxetine Hcl	Duloxetine Hcl	77	20
Chlorthalidone	Chlorthalidone	75	17
Carvedilol	Carvedilol	74	15
Atenolol	Atenolol	73	16
Famotidine	Famotidine	68	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	17
Zolpidem Tartrate	Zolpidem Tartrate	67	15
Glimepiride	Glimepiride	66	15
Allopurinol	Allopurinol	65	21
Citalopram Hbr	Citalopram Hydrobromide	63	14
Esomeprazole Magnesium	Esomeprazole Magnesium	62	14
Propranolol Hcl	Propranolol Hcl	61	12
Celecoxib	Celecoxib	59	17
Venlafaxine Hcl Er	Venlafaxine Hcl	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	55	25
Ondansetron Odt	Ondansetron	55	17
Finasteride	Finasteride	53	12
Solifenacin Succinate	Solifenacin Succinate	53	suppressed
Warfarin Sodium	Warfarin Sodium	53	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	36
Cephalexin	Cephalexin	49	21
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	13
Valsartan	Valsartan	46	suppressed
Bupropion Hcl Sr	Bupropion Hcl	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	19
Synthroid	Levothyroxine Sodium	43	suppressed
Gemfibrozil	Gemfibrozil	42	suppressed
Ozempic	Semaglutide	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Jardiance	Empagliflozin	40	11
Benazepril Hcl	Benazepril Hcl	39	suppressed
Fluconazole	Fluconazole	39	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	37	12
Clonazepam	Clonazepam	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	23
Meclizine Hcl	Meclizine Hcl	35	17
Trulicity	Dulaglutide	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	23
Aripiprazole	Aripiprazole	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Glipizide	Glipizide	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	16
Ibandronate Sodium	Ibandronate Sodium	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Brilinta	Ticagrelor	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Spironolactone	Spironolactone	23	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Mupirocin	Mupirocin	21	12
Sucralfate	Sucralfate	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Armour Thyroid	Thyroid,pork	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Ibu	Ibuprofen	19	suppressed
Lumigan	Bimatoprost	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Restasis	Cyclosporine	16	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Fentanyl	Fentanyl	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Metolazone	Metolazone	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Naproxen	Naproxen	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	11
Colestipol Hcl	Colestipol Hcl	13	suppressed
Elmiron	Pentosan Polysulfate Sodium	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Methimazole	Methimazole	12	suppressed
Modafinil	Modafinil	12	suppressed
Omnipod Dash Pods (Gen 4)	Insulin Pump Cart,cont Inf,bt	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lexapro	Escitalopram Oxalate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error